AhR Antagonist Promotes Differentiation of Papillary Thyroid Cancer via Regulating circSH2B3/miR-4640-5P/IGF2BP2 Axis

Abnormally high expression of aryl hydrocarbon receptor (AhR) has been implicated in dedifferentiation of radioiodine-refractory papillary thyroid cancer (RR-PTC). This study aimed to evaluate the differentiation effect of AhR antagonist in PTC, and to explore the potential mechanism of it. Results...

Descripción completa

Detalles Bibliográficos
Autores principales: Sa, Ri, Guo, Meiliang, Liu, Danyan, Guan, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733664/
https://www.ncbi.nlm.nih.gov/pubmed/35002727
http://dx.doi.org/10.3389/fphar.2021.795386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733664/
https://www.ncbi.nlm.nih.gov/pubmed/35002727
http://dx.doi.org/10.3389/fphar.2021.795386

Ejemplares similares